How Much Did Visit Raise?
Funding & Key Investors

Visit, an AI-driven platform focused on symptom diagnosis, lifestyle management, chronic condition care, and specialist consultations, has secured significant enterprise-level funding, with its total capital raised standing at $31.1M. The company recently announced a major strategic investment of $29.7M, underscoring its growth trajectory and market position in the health-tech sector.

What is Visit?

Visit
SoftwareHealthcare SoftwareMobile App Development

Based in New Delhi, India, Visit operates as an AI-driven health management platform. Its core functionality assists users in diagnosing symptoms, managing chronic conditions, and adopting healthier lifestyles. The platform also facilitates consultations with medical specialists, aiming to provide a comprehensive and accessible healthcare ecosystem. The recent major strategic investment suggests a scaling phase for the company, likely to expand its technological capabilities and market reach.

How much funding has Visit raised?

Visit has raised a total of $31.1M across 2 funding rounds:

2021

Angel/Seed

$1.4M

2024

Stock Offering

$29.7M

Angel/Seed (2021): $1.4M with participation from MapmyIndia, Kunal Bahl, Murali Krishna, and Rohit Bansal

Stock Issuance/Offering (2024): $29.7M led by Docprime

Key Investors in Visit

MapmyIndia

MapmyIndia, a leading provider of digital maps and geospatial technologies in India, participated in the company's early-stage funding round. Their involvement suggests a potential integration of location-based services or data analytics within Visit's health platform.

Docprime

Docprime, a comprehensive healthcare platform offering online consultations, insurance benefits, and wellness tracking, made a significant strategic investment. This backing indicates a synergistic relationship, potentially enhancing Visit's service offerings through Docprime's established healthcare network and digital solutions.

Kunal Bahl

Kunal Bahl, an individual investor, was part of the early funding for Visit. His participation highlights early confidence in the company's vision and potential for growth in the health-tech sector.

What's next for Visit?

The substantial enterprise-level backing, highlighted by the recent strategic investment, positions Visit for accelerated expansion. This capital infusion is expected to fuel advancements in its AI diagnostic tools, enhance its chronic condition management features, and broaden its network of specialist consultations. The company is poised to further solidify its presence in the health-tech landscape, potentially exploring new service offerings or geographical markets to leverage its technological innovations and address evolving healthcare needs.

See full Visit company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
Customer Engagement PlatformsSoftware
Engineering SoftwareSoftware
Business Intelligence (BI) SoftwareSoftwareEngineering Software

Frequently Asked Questions Regarding Visit Financial Insights

What are the most recent funding rounds that Visit has completed, and what were the funding rounds?
Visit has recently completed 2 funding rounds: Stock Offering on Aug 6, 2024, Angel/Seed on Oct 11, 2021.
What is the total amount of funding Visit has raised to date?
Visit has raised a total of $31.1M in funding to date.
How many funding rounds has Visit completed?
Visit has completed 2 funding rounds.
How much funding did Visit raise in its most recent funding round?
Visit raised $29.7M in its most recent funding round.
Who are the lead investors in Visit's latest funding round?
The lead investor in Visit's latest funding round was Docprime. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Visit's history?
The largest funding round in Visit's history was $29.7M.
See more information about Visit